CEO of BillionToOne INC CL A Buys Shares at $2.80, Plans to Sell at $94‑96: Rule 10b5‑1 Strategy Revealed in Insider Trades.

Insider Activity Highlights the Strategic Use of Rule 10b5‑1

On October 12, 2026, Chairman and CEO Atay Oguzhan executed a Rule 10b5‑1 buy of 16,667 Class A shares at $2.80 per share—an exceptionally low price that reflects a planned purchase of stock that is still far below the current market level of $94.44. The same day Oguzhan also sold 1,961 shares at a weighted average of $91.57 and subsequently sold a further 9,700 shares at prices ranging from $93.05 to $96.39. The pattern is unmistakable: a disciplined, rule‑based plan that first builds a position at the lowest feasible price and then unloads a portion of that position as the stock rallies.

The transaction sits against a backdrop of active insider trading within the company. In the past quarter, Oguzhan has executed both purchases and sales at a wide spectrum of prices—from the $2.80 strike on option exercises to mid‑$90s sales. His spouse and a family trust have also been involved in Rule 144 sales of thousands of shares, underscoring that insiders are comfortable with structured, compliant trading rather than opportunistic market moves.

What This Means for Investors

For investors, the current purchase suggests confidence from the CEO that the stock is undervalued. Buying at $2.80 when the market trades above $94 indicates a long‑term view and an expectation that the company’s fundamentals will support a substantial price appreciation. However, the subsequent sales at near‑market prices could be interpreted in two ways: (1) the CEO is harvesting gains as part of a pre‑planned plan, or (2) he is hedging against potential volatility as the company navigates a sector‑wide sell‑off. Either scenario signals that the company’s top management is actively managing personal exposure while maintaining a bullish stance on the business.

The broader insider activity also provides context. While other executives have taken large sales in the $90s range, the overall volume of insider trading has remained moderate. This balance—executives buying and selling under a structured plan—suggests that the board is not overly concerned about liquidity or short‑term market sentiment, but rather focuses on long‑term value creation.

Atay Oguzhan: A Profile of Discipline and Long‑Term Vision

Oguzhan’s transaction history reveals a consistent pattern: a high‑volume, rule‑based purchase at a steep discount, followed by a staggered sell‑off as the stock climbs. This approach aligns with a classic “rule 10b5‑1” strategy, designed to avoid the appearance of insider trading while still allowing the CEO to benefit from the company’s upside. His option exercise history—selling 16,667 shares at $2.80 and 10,000 shares at $2.80—confirms that he prefers to lock in gains at the strike price rather than gamble on short‑term price movements.

Beyond the mechanics, Oguzhan’s trading volume suggests confidence in the company’s trajectory. Despite a year‑to‑date decline of 10.15 % and a price‑earnings ratio of 137.73, he continues to purchase shares, indicating that he believes the underlying health‑care platform is poised for future growth. His actions also demonstrate a willingness to use structured plans to balance personal investment with fiduciary responsibility—an attractive quality for investors wary of potential conflicts of interest.

Looking Ahead

BillionToOne’s recent insider activity, particularly Oguzhan’s disciplined Rule 10b5‑1 trades, signals a long‑term commitment to the company’s vision. While the current market conditions are challenging—weekly gains of 2.23 % but a yearly loss of 10.15 %—the CEO’s buying power at a deep discount suggests he sees a compelling upside. For investors, the takeaway is clear: if you believe in BillionToOne’s health‑care strategy and its ability to navigate a volatile market, the insider’s actions may serve as a green light. Conversely, if you remain skeptical of the company’s prospects, the pattern of staggered selling could be a warning that insiders are preparing for potential downside.